CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. The Company's BAC arrays enable the Company to perform aCGH studies to evaluate genomic alterations. The Company's oligo arrays allow the Company to perform aCGH on a much more refined scale than is possible with BAC technology. During the year ended December 31, 2011, it also owns a 33% interest in Leuchemix, Inc. (Leuchemix), a private drug development company focused on developing a series of compounds to address a number of oncology-related diseases.
|Headquarters||SUITE 150, 310 GODDARD|
IRVINE, CA, United States 92618
|Chairman of the Board, President, Chief Executive Officer||R Jessup|
|Chief Financial Officer, Treasurer, Secretary||Scott Burell|
|Chief Medical Officer||Richard Hockett|
|Independent Director||Wei Ding|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P Capital IQ, INK and Argus.
|Shares Out.||8.9M||Book Value||$-0.48|
|Annual Dividend Rate||$0.00||Price/Sales (TTM)||4.4|
|Ex-Div Date||1/1/01||P/Cash Flow (TTM)||--|
|Pay Date||1/1/01||Operating Margin||-96.05%|
*GAAP = prior to non-GAAP analyst adjusted earnings.